Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Retraction

Retraction: Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies

  • The PLOS ONE Editors

After this article was published, similarities were noted between this article and submissions by other research groups which call into question the validity and provenance of the reported results. In addition, during editorial follow-up, a number of data extraction errors were found, meaning some of the conclusions are no longer supported.

In light of these issues, PLOS ONE cannot stand by the reliability of the reported research, and the PLOS ONE Editors retract this article [1].

JZ did not respond to the final editorial decision. CM, AX, KZ, ZQ, XL, CL, YH, WC, CZ, YL, SS, ZW, and BL either did not respond directly or could not be reached.

Reference

  1. 1. Zhang J, Miao C, Xu A, Zhao K, Qin Z, Li X, et al. (2016) Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies. PLoS ONE 11(8): e0161150. https://doi.org/10.1371/journal.pone.0161150

Citation: The PLOS ONE Editors (2023) Retraction: Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies. PLoS ONE 18(5): e0285567. https://doi.org/10.1371/journal.pone.0285567

Published: May 4, 2023

Copyright: © 2023 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.